Tudorza Pressair (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the Tudorza Pressair drug offered from AstraZeneca Pharmaceuticals LP. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
NON-PROPRIETARY NAME: | aclidinium bromide |
SUBSTANCE NAME: | ACLIDINIUM BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | INHALANT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-07-01 |
END MARKETING DATE: | 0000-00-00 |
Tudorza Pressair HUMAN PRESCRIPTION DRUG Details:
Item Description | Tudorza Pressair from AstraZeneca Pharmaceuticals LP |
LABELER NAME: | AstraZeneca Pharmaceuticals LP |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(ug/1) |
START MARKETING DATE: | 2015-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0310-0800_b0423fc4-a73b-4542-9792-2e5fc54ae6ce |
PRODUCT NDC: | 0310-0800 |
APPLICATION NUMBER: | NDA202450 |
Other ACLIDINIUM BROMIDE Pharmaceutical Manufacturers / Labelers: